Celldex Therapeutics, Inc. CLDX
28.27 USD -1.66 (-5.55%)
At closeNov 5, 2026, 4:03 PM EST
28.08 -0.19 -0.67%
After hours · Nov 5, 4:03 PM ET
28.21 Day range 30.00
22.10 52-week range 45.14
- YTD
- +4.09%
- 1 year
- +19.13%
Ownership
Held by insiders 0.27%
Held by institutions 109.84%
Float held by institutions 110.14%
Institutions 346
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Wellington Management Group, LLP | 12.15% | 9,543,671 | 285.64M | Jun 29, 2026 |
| Blackrock Inc. | 8.92% | 7,002,530 | 209.59M | Jun 29, 2026 |
| Kynam Capital Management, LP | 6.78% | 5,322,908 | 159.31M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.97% | 4,685,223 | 140.23M | Jun 29, 2026 |
| State Street Corporation | 4.97% | 3,900,427 | 116.74M | Jun 29, 2026 |
| FMR, LLC | 4.74% | 3,722,888 | 111.43M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 4.82% | 3,783,994 | 113.25M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 2,487,758 | 74.46M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.57% | 2,020,869 | 60.48M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.04% | 1,603,138 | 47.98M | Sep 29, 2026 |
| Vanguard Explorer Fund | 1.84% | 1,447,608 | 43.33M | Jul 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.60% | 1,254,603 | 37.55M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JIMENEZ FREDDY A | General Counsel | Sale | Dec 3, 2025 | 30,796 |
| MARINO JAMES J | Director | Stock Gift | Nov 17, 2024 | 2,204 |
| MARTIN SAMUEL BATES | Chief Financial Officer | Conversion of Exercise of derivative security | Jan 1, 2026 | 32,942 |
| PEPIN RONALD A | Officer | Conversion of Exercise of derivative security | Dec 14, 2025 | 20,097 |
| WRIGHT RICHARD M | Former | Sale | Nov 12, 2025 | 20,833 |